Inside Atopic Dermatitis: The Dupixent (Dupilumab) Podcast Series

Dupixent (dupilumab) Prescribing Information UK

In this insightful episode, Dr Hywel Cooper, Consultant Dermatologist and Research Lead at Portsmouth Hospital, explores the profound impact of atopic dermatitis on patients’ quality of life. From the challenges of hand eczema and sleep disruption to the emotional toll on families and the importance of personalised care, Dr Cooper shares clinical experience and practical strategies for improving outcomes. A must-listen for healthcare professionals seeking to understand the lived experience of AD.

In this episode, Dr Antonia Lloyd-Lavery, Consultant Dermatologist at Oxford University Hospitals, discusses the often-overlooked comorbidities associated with atopic dermatitis (AD). From asthma and allergic rhinitis to ocular complications, Dr Lloyd-Lavery shares her clinical insights on holistic patient assessment, and the importance of personalised care. A valuable listen for healthcare professionals aiming to optimise long-term outcomes for patients aged 12+ with moderate-to-severe AD.

In this episode, Dr Gabriela Petrof, Consultant Dermatologist at Great Ormond Street Hospital, shares her expertise in treating paediatric patients with severe atopic dermatitis. She discusses the unique challenges of managing AD in children and adolescents, the importance of family dynamics, and the evolving treatment landscape-including the role of biologics and timely intervention. A thoughtful and compassionate look at how personalised care can improve outcomes and quality of life for young patients and their families.

Dr Andrew Pink, Consultant Dermatologist at Guy’s and St Thomas’ Hospital, joins the podcast to discuss the evolving treatment landscape in atopic dermatitis and the importance of comparative data. He introduces the BEACON trial, a UK-wide, multi-arm study comparing systemic therapies including dupilumab, methotrexate, and ciclosporin, and shares insights on trial design, patient monitoring, and multidisciplinary care. A must-listen for clinicians navigating treatment options and seeking evidence-based clarity in AD management.

Dr Richard Woolf, Consultant Dermatologist and Clinical Lead at Guy’s and St Thomas’, shares his expert perspective on the evolving role of targeted therapies in the management of atopic dermatitis. From real-world experience with biologics like dupilumab and tralokinumab to collaborative care with ophthalmology and navigating NICE guidance, Dr Woolf offers practical insights into treating high-impact sites and improving patient pathways. A valuable listen for clinicians seeking clarity on treatment options and multidisciplinary best practices in AD care.